INSIGHTS ON QUALITY CONTROL
-
Pharmaceutical X-Ray Counts Capsules & Pills
Learn how advanced X-ray inspection ensures exact pill counts in multi-supplement pouches, automatically identifying missing components and generating time-stamped visual data logs.
-
Designing An Environmental Monitoring Solution For GMP Applications
Implement robust contamination control strategies that align with current regulatory requirements. Optimize your environmental monitoring framework through precise design and data-driven analysis.
-
FDA's Risk-Based Inspection Shift: What It Actually Rewards
FDA’s revised pre-approval inspection program prioritizes risk-based determinations over routine site visits. Review risk assessment factors and transition toward continuous audit readiness.
-
PDA TR33 And The Case For Rapid Methods In H₂O₂ Bio-Decontamination
The updated 2026 PDA Technical Report No. 33 offers a framework for qualifying alternative and rapid microbiological methods against traditional standards for regulatory compliance.
-
Inside The Cleanroom: Training Beyond The Checkbox2/12/2026
Effective cleanroom management requires moving beyond checkbox compliance. Learn how to empower your workforce by connecting individual roles to broader contamination control goals and behaviors.
-
How To Use Enzyme Indicators In An Aseptic Production Environment6/30/2026
Discover how transitioning to quantitative validation data allows engineering teams to optimize decontamination timelines, slash system downtime, and minimize product carryover risks.
-
Active Air Sampler Comparison In Remote Settings9/9/2026
Discover how optimized air sampler geometry improves microbial collection efficiency and continuous environmental monitoring accuracy to safeguard critical cleanroom operations.
-
Extraction And Chemical Characterization Pitfalls In Complex Medical Devices8/20/2026
Standard extraction protocols routinely fail tissue-derived products, hydrogels, absorbables, and silicone implants. Learn the material-specific study design strategies that prevent regulatory rejection and repeat work.
-
503A Vs. 503B: Turning Regulatory Complexity Into Practical Compliance4/20/2026
Navigating human drug compounding requires aligning Section 503A and Section 503B operations with cGMP expectations, robust quality management systems, and standing inspection readiness.
QUALITY CONTROL SOLUTIONS
-
Upperton offers analytical services designed to support the development, monitoring, and quality control testing of pharmaceutical products.
-
PTI Inspection Systems are scientific instruments being deployed for high risk packaging applications. The environments in which these systems operate is often highly regulated with test results having a significant impact on operational decisions. The reliability and sensitivity of a CCI test method is critical to assure that correct decisions are made to maintain product quality and patient safety. If PTI’s equipment is going to test your packaging, we aim to deliver the most effective solution. Feasibility studies offer a detailed glimpse into the technological capabilities ahead of critical purchasing decisions. Feasibility studies can also act as a preliminary test method for an application. The results from feasibility or method development testing can be rolled out to the production environment for rapid validation and deployment.
-
Protect your lab and ensure weighing accuracy with specialized containment enclosures. These units neutralize air turbulence and capture hazardous powders to maintain a safe, high-precision workspace.
-
Designed for pharmaceutical quality control and microbiology laboratories.
-
Active bead release gives manufacturers precise control over T cell isolation timing, phenotype preservation, and workflow efficiency, eliminating multi-day passive dissociation delays.